Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...
N.Y., decried the cuts as illegal and rooted in a willful misunderstanding of how medical research is conducted at ...
The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.
Over the past few weeks, the Trump administration has introduced sweeping changes across the federal government that have impacted the federal ...
Georgia Life Sciences said that the immediate impact on university research would cause downstream harm to the biomedical industry in the state.
In statements and interviews with The Crimson, nine life sciences researchers at Harvard — from the Harvard School of Public ...
Of course the effects will vary across research institutions, as institutions differ markedly in their operating models and ...
The National Institutes of Health’s Office of the Director issued a policy change notice Feb. 7, announcing that the standard rate of indirect costs would be 15% for all current and future grants. The ...
On February 7, the NIH announced that it would begin capping indirect cost payments for new and existing research grants at 15%.
Keyera released both its fourth-quarter and full-year 2024 results. After digesting the news, we maintain our CAD 41 fair value estimate.
Put simply, a tariff is a tax placed on the cost of importing or exporting goods by a certain country. A 60% tariff on Chinese imports would therefore be a 60% tax on the cost to import, say, computer ...
Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results